Autoimmune Photodermatoses Part II - Clinical Manifestations and Treatment
Abstract
The autoimmune photodermatoses are a group of heterogeneous idiopathic dermatoses including five different clinical entities some potentially severe with great impact in patients’ quality of life. General photoprotection measures are sufficient for the treatment of patients with mild forms of disease. In severe disease the therapeutic options are still limited, reflecting the ill-defined physiopathological mechanisms. However recent advances in photoprotection field are contributing to a higher therapeutic success. In an era where photodermatology has been losing its importance, we propose to revise the clinical manifestations and therapeutic options of autoimmune photodermatoses. These are rare and challenging disorders concerning diagnostic and treatment that need a specialized approach by dermatologists.
Downloads
References
Gruber-Wackernagel A, Byrne SN, Wolf P. Pathogenic
mechanisms of polymorphic light eruption. Front Biosci.
; 1:341-54.
Wolf P, Byrne SN, Gruber-Wackernagel A. New insights
into the mechanisms of polymorphic light eruption: resistance
to ultraviolet radiationinduced immune suppression
as an aetiological factor. Exp Dermatol. 2009;
:350-6.
Gruber-Wackernagel A, Byrne SN, Wolf P. Polymorphous
light eruption: clinic aspects and pathogenesis. Dermatol
Clin. 2014; 32:315-34.
Gonzalez E, Gonzalez S. Drug photosensitivity, idiopathic
photodermatoses, and sunscreens. J Am Acad Dermatol.
; 35:871-85.
Jansen CT, Karvonen J. Polymorphous light eruption. A
seven-year follow-up evaluation of 114 patients. Arch
Dermatol. 1984; 120:862-5.
Richards HL, Ling TC, Evangelou G, Brooke RC, Fortune
DG, Rhodes LE. Evidence of high levels of anxiety and
depression in polymorphic light eruption and their association
with clinical and demographic variables. Br J
Dermatol. 2008; 159:439-44.
Lava SA, Simonetti GD, Ragazzi M, Guarino Gubler S,
Bianchetti MG. Juvenile spring eruption: an outbreak report
and systematic review of the literature. Br J Dermatol.
; 168:1066-72.
Guarrera M, Cardo P, Rebora AE, Schena D, Calzavara-
-Pinton P, Venturini M, et al. Polymorphous light eruption
and benign summer light eruption in Italy. Photodermatol
Photoimmunol Photomed. 2011; 27:35-9.
Molina-Ruiz AM, Sanmartin O, Santonja C, Kutzner H,
Requena L. Spring and summer eruption of the elbows:
a peculiar localized variant of polymorphous light eruption.
J Am Acad Dermatol. 2013; 68:306-12.
Hjorth N, Sjolin KE, Sylvest B, Thomsen K. Acne aestivalis
— Mallorca acne. Acta Derm Venereol. 1972; 52:61-3.
Waters AJ, Sandhu DR, Green CM, Ferguson J. Solar capillaritis
as a cause of solar purpura. Clin Exp Dermatol.
; 34:821-4.
Ling TC, Richards HL, Janssens AS, Anastassopoulou L,
Antoniou C, Aubin F, et al. Seasonal and latitudinal impact
of polymorphic light eruption on quality of life. J
Invest Dermatol. 2006; 126:1648-51.
Nyberg F, Hasan T, Puska P, Stephansson E, Häkkinen
M, Ranki A, et al. Occurrence of polymorphous light
eruption in lupus erythematosus. Br J Dermatol. 1997;
:217-21.
Millard TP, Lewis CM, Khamashta MA, Hughes GR, Hawk
JL, McGregor JM. Familial clustering of polymorphic light
eruption in relatives of patients with lupus erythematosus:
evidence of a shared pathogenesis. Br J Dermatol.
;144:334-8.
Grabczynska SA, McGregor JM, Kondeatis E, Vaughan
RW, Hawk JL. Actinic prurigo and polymorphic light eruption:
common pathogenesis and the importance of HLA-
-DR4/DRB1*0407. Br J Dermatol. 1999; 140:232-6.
Hojyo-Tomoka T, Vega-Memije E, Granados J, Flores
O, Cortés-Franco R, Teixeira F, et al. Actinic prurigo: an
update. Int J Dermatol. 1995; 34:380-4.
Crouch R, Foley P, Baker C. Actinic prurigo: a retrospective
analysis of 21 cases referred to an Australian photobiology
clinic. Australas J Dermatol. 2002; 43:128-32.
Valbuena MC. Actinic prurigo. Dermatol Clin. 2014;
:335-44.
Lane PR, Hogan DJ, Martel MJ, Reeder B, Irvine J. Actinic
prurigo: clinical features and prognosis. J Am Acad Dermatol.
; 26:683-92.
Addo HA. Frain-Bell W. Actinic prurigo - a specific photodermatosis?
Photodermatol. 1984; 1:119-28.
Herrera-Geopfert R, Magaña M. Follicular cheilitis. A distinctive
histopathologic finding in actinic prurigo. Am J
Dermatopathol. 1995; 17:357-61.
Jong CT, Finlay AY, Pearse AD, Kerr AC, Ferguson J, Benton
EC, et al. The quality of life of 790 patients with photodermatoses.
Br J Dermatol. 2008;159:192-7.
Nitiyarom R, Wongpraparut. Hydro vacciniforme and
Solar Urticaria. Dermatol Clin. 2014; 32:425-53.
Trikha S, Turnbull A, Srikantha N, Krishnan R, Tappin A.
Anterior keratouveitis secondary to hydroa vacciniforme:
a role for ophthalmic slit-lamp examination in this condition?
BMJ Case Rep. 2011.
Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S,
Ohtsuka M, et al. Pathogenic link between hydroa vacciniforme
and Epstein-Barr virus-associated hematologic
disorders. Arch Dermatol. 2006; 142:587-95.
Cho KH, Lee SH, Kim CW, Jeon YK, Kwon IH, Cho YJ, et
al. Epstein-Barr virus associated lymphoproliferative lesions
presenting as a hydroa vacciniforme-like eruption:
an analysis of six cases. Br J Dermatol. 2004; 151:372-
Yamamoto T, Hirai Y, Miyake T, Yamasaki O, Morizane S,
Iwatsuki K. Oculomucosal and gastrointestinal involvement
in Epstein-Barr virus- associated hydroa vacciniforme.
Eur J Dermatol. 2012; 22:380-3.
Paek SY, Lim HW. Chronic actinic dermatitis. Dermatol
Clin. 2014; 32:355-61.
Forsyth EL, Millard TP. Diagnosis and pharmacological
treatment of chronic actinic dermatitis in the elderly: an
update. Drugs Aging. 2010; 27:451-6.
Lim HW, Cohen D, Soter NA. Chronic actinic dermatitis:
results of patch and photopatch tests with Compositae,
fragrances, and pesticides. J Am Acad Dermatol. 1998;
:108-11.
Russell SC, Dawe RS, Collins P, Man I, Ferguson J. The
photosensitivity dermatitis and actinic reticuloid syndrome
(chronic actinic dermatitis) occurring in seven
young atopic dermatitis patients. Br J Dermatol. 1998;
:496-501.
Meola T, Sanchez M, Lim HW, Buchness MR, Soter NA.
Chronic actinic dermatitis associated with human immunodeficiency
virus infection. Br J Dermatol. 1997;
:431-6.
Somani VK. Chronic actinic dermatitis — a study of clinical
features. Indian J Dermatol Venereol Leprol. 2005;
:409-13.
Dawe RS, Crombie IK, Ferguson J. The natural history
of chronic actinic dermatitis. Arch Dermatol. 2000;
:1215-20.
Norris PG, Morris J, Smith NP, Chu AC, Hawk JL. Chronic
actinic dermatitis: an immunohistologic and photobiologic
study. J Am Acad Dermatol. 1989; 21:966-71.
Agar N, Morris S, Russell-Jones R, Hawk J, Whittaker
S. Case report of four patients with erythrodermic cutaneous
T-cell lymphoma and severe photosensitivity mimicking
chronic actinic dermatitis. Br J Dermatol. 2009;
:698-703.
Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. Characteristics
and prognosis of idiopathic solar urticaria: a cohort
of 87 cases. Arch Dermatol. 2003;139:1149-54.
Horio T. Solar urticaria — idiopathic? Photodermatol
Photoimmunol Photomed. 2003;19:147-54.
Tuchinda C, Leenutaphong V, Sudtim S, Lim HW. Fixed
solar urticaria induced by UVA and visible light: a report
of a case. Photodermatol Photoimmunol Photomed.
; 21:97-9.
Wessendorf U, Hanneken S, Haust M, Neumann NJ.
Fixed solar urticaria with delayed onset. J Am Acad Dermatol.
; 60:695-7.
Kurumaji Y, Shono M. Drug-induced solar urticaria due
to repirinast. Dermatology. 1994; 188:117-21.
Yap LM, Foley PA, Crouch RB, Baker CS. Drug-induced
solar urticaria due to tetracycline. Australas J Dermatol.
; 41:181-4.
Faurschou A. Evidence-Based Guidelines for the Classification
and Management of the Photodermatoses. Section
Photoprotection. Paris: European Dermatology
Forum Guidelines; 2009.
Bissonnette R. Prevention of polymorphous light eruption
and solar urticaria. Skin Ther Lett. 2002; 7:3-5.
Azurdia RM, Pagliaro JA, Diffey BL, Rhodes LE. Sunscreen
application by photosensitive patients is inadequate for
protection. Br J Dermatol. 1999; 140:255-58.
Lademann J, Schanzer S, Jacobi U, Schaefer H, Pflücker
F, Driller H, et al. Synergy effects between organic and
inorganic UV filters in sunscreens. J Biomed Opt. 2005;
:140-8.
Bissonnette R, Nigen S, Bolduc C. Influence of the quantity
of sunscreen applied on the ability to protect against
ultraviolet-induced polymorphous light eruption. Photodermatol
Photoimmunol Photomed. 2012; 28:240-3.
Hoffmann K, Laperre J, Avermaete A, Altmeyer P, Gambichler
T. Defined UV protection by apparel textiles. Arch
Dermatol. 2001; 137:1089-94.
Gambichler T, Avermaete A, Bader A, Altmeyer P, Hoffmann
K. Ultraviolet protection by summer textiles.
Ultraviolet transmission measurements verified by determination
of the minimal erythema dose with solar-simulated
radiation. Br J Dermatol. 2001; 144:484-89.
Bech-Thomsen N, Ravnborg L, Wulf HC. Quantitative
study of the melanogenic effect of multiple suberythemal
doses of different ultraviolet radiation sources. Photodermatol
Photoimmunol Photomed. 1994; 10:53-6.
Hönigsmann H. Mechanism of phototherapy and photochemotherapy
for photodermatoses. Dermatol Ther.
; 16:23-7.
Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JL,
Magnus IA. Prophylactic PUVA and UVB therapy in polymorphic
light eruption - a controlled trial. Br J Dermatol.
; 116:531-8.
George SA, Gibbs NK, Aitchison T, Johnson BE, Ferguson
JA. Comparison of narrow-band phototherapy
(Tl-01) and photochemotherapy (PUVA) in the management
of polymorphic light eruption. Br Dermatol. 1993;
:708-12.
SCENIHR (Scientific Committee on Emerging and Newly
Identified Health Risks). Health effects of artificial light.
Brussels: European Comission; 2012.
Moise AF, Aynsley R. Ambient ultraviolet radiation levels
in public shade settings. Int J Biometeorol. 1999;
:128-38.
Murphy GM, Hawk JL, Magnus IA. Hydroxychloroquine
in polymorphic light eruption: a controlled trial with drug
and visual sensitivity monitoring. Br J Dermatol. 1987;
:379-86.
Marini A, Jaenicke T, Grether-Beck S, Le Floc'h C, Cheniti
A, Piccardi N, et al. Prevention of polymorphic light
eruption by oral administration of a nutritional supplement
containing lycopene, ss-carotene and Lactobacillus
johnsonii: results from a randomized, placebo-controlled,
double-blinded study. Photodermatol Photoimmunol
Photomed. 2013; 30:189-94.
Caccialanza M, Percivalle S, Piccinno R, Brambilla R. Photoprotective
activity of oral polypodium leucotomos extract
in 25 patients with idiopathic photodermatoses. Photodermatol
Photoimmunol Photomed. 2007; 23:46-7.
Tanew A, Radakovic S, Gonzalez S, Venturini M, Calzavara-
Pinton P. Oral administration of a hydrophilic extract
of Polypodium leucotomos for the prevention of polymorphic
light eruption. J Am Acad Dermatol. 2012; 66:58-
60. Kohli I, Shafi R, Isedeth P, Griffith JL, Al-Jamal MS,
Silpa-Archa N, et al. The impact of oral Polypodium leucotomos
extract on ultraviolet B response: a human clinical
study. J Am Acad Dermatol. 2017; 77:33-41.
Dam TN, Moller B, Hindkjaer J, Kragballe K. The vitamin
D3 analog calcipotriol suppresses the number and
antigen-presenting function of Langerhans cells in normal
human skin. J Investig Dermatol Symp Proc. 1996;
:72-7
Yarosh DB, O’Connor A, Alas L, Potten C, Wolf P. Photoprotection
by topical DNA repair enzymes: molecular
correlates of clinical studies. Photochem Photobiol.
; 69:136-40.
Yarosh D, Klein J, O’Connor A, Hawk J, Rafal E, Wolf P.
Effect of topically applied T4 endonuclease V in liposomes
on skin cancer in xeroderma pigmentosum: a randomized
study. Xeroderma Pigmentosum Study Group.
Lancet. 2001; 357:926-9.
Fabrikant J, Touloei K, Brown SM. A review and update
on melanocyte stimulating hormone therapy: afamelanotide.
J Drugs Dermatol. 2013; 12:775-9.
Millard TP. Treatment of polymorphic light eruption. J
Dermatol Treat. 2000; 11:195-9.
Molin L, Volden G. Treatment of polymorphous light
eruption with PUVA and prednisolone. Photodermatol.
; 4:107-8.
Norris PG, Hawk JL. Successful treatment of severe polymorphous
light eruption with azathioprine. Arch Dermatol.
; 125:1377-9.
McCoombes JA, Hirst LW, Green WR. Use of topical
cyclosporin for conjunctival manifestations of actinic prurigo.
Am J Ophthalmol. 2000; 130:830-1.
Ferguson J, Ibbotson S. The idiopathic photodermatoses.
Semin Cutan Med Surg. 1999; 18:257-73.
Jacobson J. Thalidomide: a remarkable comeback. Expert
Opin Pharmacother. 2000;1:849-63.
Sampaio E, Sarno E, Galilly R, Cohn ZA, Kaplan G. Thalidomide
selectively inhibits tumor necrosis alpha production
by stimulated human monocytes. J Exp Med.
;173:699-703.
Torres-Alvarez B, Castanedo-Cazares JP, Moncada B.
Pentoxifylline in the treatment of actinic prurigo. A preliminary
report of 10 patients. Dermatology. 2004;
:198-201.
Hawk J. Evidence-Based Guidelines for the Classification
and Management of the Photodermatoses. Section I. The
Auto-Immune Photodermatoses. Paris: European Dermatology
Forum Guidelines; 2009.
Suga Y, Hashimoto Y, Matsuba S, Mizoguchi M, Ogawa
H. Topical tacrolimus for chronic actinic dermatitis. J Am
Acad Dermatol. 2002; 46:321-3.
Gardeazabal J, Arregui MA, Gil N, Landa N, Ratón JA,
Diáz-Pérez JL. Successful treatment of musk ketone-induced
chronic actinic dermatitis with cyclosporine and
PUVA. J Am Acad Dermatol. 1992; 27:838-42.
Murphy GM, Maurice PD, Norris PG, Morris RW, Hawk
JL. Azathioprine treatment in chronic actinic dermatitis: a
double-blind controlled trial with monitoring of exposure
to ultraviolet radiation. Br J Dermatol. 1989; 121:639-46.
Thomson MA, Stewart DG, Lewis HM. Chronic actinic
dermatitis treated with mycophenolate mofetil. Br J Dermatol.
; 152:784-6.
Adamski H, Bedane C, Bonnevalle A, Thomas P, Peyron
JL, Rouchouse B, et al. Solar urticaria treated with intravenous
immunoglobulins. J Am Acad Dermatol. 2011;
:336-40.
Waibel KH, Reese DA, Hamilton RG, Devillez RL. Partial
improvement of solar urticaria after omalizumab. J Allergy
Clin Immunol. 2010; 125:490-1.
Haylett AK, Nie Z, Brownrigg M, Taylor R, Rhodes LE.
Systemic photoprotection in solar urticaria with alphamelanocyte-
stimulating hormone analogue [Nle4- D-
-Phe7]-alpha-MSH. Br J Dermatol 2011; 164:407-14.
Collins P, Ahamat R, Green C, Ferguson J. Plasma exchange
therapy for solar urticaria. Br J Dermatol.1996;
:1093-7.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
